Diabetes Mellitus, Hypertension, Medication Adherence
Conditions
Keywords
Pharmaceutical care, Medication Adherence, Blood Pressure, Diabetes, Emergency
Brief summary
The purpose of this study is to evaluate the effectiveness of pharmaceutical care, compared to usual care, in patient discharge in an emergency department in patients with hypertension and/or diabetes mellitus type 2.
Detailed description
This is a randomized controlled, single-center study, with blinding of outcome assessors. A pilot study with ten patients was previously conducted in order to test study logistics and data collection instruments. Participants will be recruited from a public ED at Restinga district in Porto Alegre, southern Brazil.
Interventions
OTHERPharmaceutical care
The clinical pharmacist will provide a structured 30-minute intervention for enhancing their medication adherence. The recommendations include: discussion on hypertension and/or diabetes, risk of complications, prescribed drug therapy, correct use of medications and proper dosage, possible adverse effects, route of administration, schedule of administration and correct storage. The pharmacist will also emphasize the importance of lifestyle modifications. Printed educational material, with information on hypertension and/ or diabetes medications, including suggested lifestyle interventions was prepared to assist in the intervention and will be handed to patients in the end of the session.
Sponsors
Ministry of Health, Brazil
Hospital Moinhos de Vento
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Blood pressure inadequate control (systolic blood pressure ≥ 160 or diastolic blood pressure ≥ 100 mmHg) or * Diabetes mellitus inadequate Control( ≥ 200 mg/dL) or hypoglycemia moderate or severe * Be referred to clinical care.
Exclusion criteria
* \< 18 years * Not resident of Porto Alegre * Diabetes mellitus type I * Unable to answer the questionnaire or to sign the informed consent form * Hospital admission * Death
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Medication Adherence | Two months | Outcome of interest: High Adherence According to the Brief Medication Questionnaire and Morisky-Green Test |
Secondary
| Measure | Time frame |
|---|---|
| Blood Pressure Control | Two months |
| Glycated hemoglobin (HbA1C) for diabetic patients | two months |
| Quality of Life | Two months |
Other
| Measure | Time frame |
|---|---|
| Fasting plasma glucose for diabetic patients | Two months |
Countries
Brazil
Outcome results
None listed